Search clinical trials for: SeQuent® Please Neo

Total 830 results

IPCA Laboratories Ltd.

Completed

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition

Fasting

India
Eric Albrecht

Recruiting

Efficacy of Erector Spinae Plane Block for Postoperative Analgesia in Adult Patients Undergoing Thoracoscopy

Pain, Postoperative

Switzerland
M.D. Anderson Cancer Center
Amgen

Recruiting

A Phase II Study of Neoadjuvant Sotorasib in Combination With Cisplatin or Carboplatin and Pemetrexed for Surgically Resectable Stage IIA-IIIB Non-Squamous Non-Small Cell Lung Cancer With a KRAS p.G12C Mutation

Lung Cancer

United States
Medical University of Vienna

Completed

Treatment of the Intermediate Vaginal Microbiota With Vaginal Lactobacillus Casei Rhamnosus to Improve Pregnancy Outcome (LCR35&PTD)

Lactobacillus Infection

Austria
Actavis Inc.

Completed

A Relative Bioavailability Study of Metformin HCl 750 mg ER Tablets Under Fasting Conditions

Healthy

United States
Eli Lilly and Company
University of Colorado, Denver; Quintiles, Inc.; PPD; Parexel; Laboratory Corporation... and other collaborators

Completed

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin (INSPIRE)

Non Small Cell Lung Cancer

Belgium, Brazil, Russian Federation, United Kingdom, Australia, Germany, Hungary, Italy, Romania, United States, Austria, Canada, Croatia, France, Greece, Poland, Portugal, Slovakia, South Africa, Spain
EMD Serono Research & Development Institute, Inc.

Completed

Oral Cladribine in Early Multiple Sclerosis (MS) (ORACLE MS)

Multiple Sclerosis

Lebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
Naval Medical Center Camp Lejeune

Recruiting

BOTOX® vs. XEOMIN® for Chronic Migraine

Chronic Migraine

United States
Astellas Pharma Inc
Astellas Pharma Canada, Inc.

Completed

Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers

Healthy

Canada
Bristol-Myers Squibb

Withdrawn

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone (SUPPRESS)

HIV

United States
Merz Pharmaceuticals GmbH

Completed

NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines (Head2Head)

Glabellar Frown Lines

United Kingdom, Germany, Austria
Sidney Kimmel Comprehensive Cancer Center at Johns...
Believe Big

Completed

Trial of Mistletoe Extract in Patients With Advanced Solid Tumors

Solid Tumor

United States
Merck Sharp & Dohme LLC

Active, not recruiting

KEYMAKER-U01 Substudy 1: Efficacy and Safety Study of Pembrolizumab (MK-3475) Plus Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Advanced Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)

Carcinoma, Non-Small-Cell Lung

Poland, United States, Hungary, Israel, Italy, Korea, Republic of, Spain
Desitin Arzneimittel GmbH
FGK Clinical Research GmbH

Completed

Influence of Piribedil (Clarium®) on Vigilance and Cognitive Function in Patients With Parkinson's Disease Compared to Other Non-Ergot Dopamine Agonists (PIVICOG-PD)

Idiopathic Parkinson's Disease

Germany
Allergan

Completed

Patient Satisfaction Study of Combined Facial Treatment With BOTOX® Cosmetic, JUVÉDERM® and LATISSE® (HARMONY Study)

Glabellar Lines | Nasolabial Fold | Crow's Feet Lines | Facial Rhytides

United States
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Oxybutynin Chloride Extended-Release Tablets 15 mg and Ditropan XL® Tablets 15 mg

Healthy

United States
Medical College of Wisconsin

Recruiting

Botulinum Toxin A for the Treatment of Chemotherapy Induced Peripheral Neuropathy

Peripheral Neuropathy Due to Chemotherapy

United States
Rajavithi Hospital

Completed

Neubotulinum Toxin Injection in Cerivical Dystonia (NTCD)

Cervical Dystonia

Thailand
Brazilan Center for Studies in Dermatology

Completed

Fields Of Effects Of Two Commercial Preparations Of Botulinum Toxin Type A At Equal Labeled Unit Doses

Skin Wrinkling

Brazil
Zhujiang Hospital

Recruiting

Safety and Efficacy of Botulinum Toxin A for Treatment of Overactive Bladder in Parkinson's Disease

Overactive Bladder | Parkinson's Disease | Onabotulinumtoxin A

China
Hugel
Sihuan Pharmaceutical Limited

Completed

Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines.

Glabellar Lines

Korea, Republic of
Luye Pharma Group Ltd.

Completed

Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Prostate Cancer

China
Danone Research

Completed

Effect of the Consumption of a Fermented Milk on Common Infections in Shift-workers

Respiratory Tract Infections | Pneumonia | Gastroenteritis | Sinusitis | Influenza | Healthy Subjects | Otitis | Infectious Diseases | Bronchitis | Sore Throat

Germany
Mundipharma Korea Ltd

Completed

Efficacy of Lodotra®(Prednisone) in Reduction of Morning Stiffness Duration(K-IMPROvE)

Rheumatoid Arthritis

Korea, Republic of
Meda Pharmaceuticals

Completed

A Study to Evaluate Two Formulations of Carisoprodol in Subjects With Musculoskeletal Spasm of the Lower Back

Lower Back Pain

United States
Allergan

Completed

An Observational Retrospective Study to Evaluate Treatment Patterns of Botulinum Toxin Type A

Facial Rhytides

Argentina
Medy-Tox

Completed

The Efficacy and Safety of MEDITOXIN® in Children With Cerebral Palsy

Muscle Spasticity

Korea, Republic of
Allergan

Completed

Comparison of Efficacy and Safety of Two Different Types of Botulinum Toxin Type A in Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Poland, Turkey, Italy, Croatia, Australia
Allergan

Completed

Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease

Dry Eye Syndromes

Canada, Australia
M.D. Anderson Cancer Center
Eisai Inc.

Recruiting

Phase II Study of Pembrolizumab in Combination With Lenvatinib in Patients With TNBC, NSCLC, and Other Tumor Types and Brain Metastases

Tumor | Brain Metastases

United States
Bioeq GmbH

Completed

Efficacy and Safety of the Aflibercept FYB203 Biosimilar in Comparison to Eylea® in Patients With Neovascular Age-Related Macular Degeneration (MAGELLAN-AMD)

Neovascular Age-related Macular Degeneration

Bulgaria, Italy, Poland, Russian Federation, Hungary, Ukraine, Japan, Israel, Czechia
NanoAlvand

Completed

Alvopem® (Pemetrexed) Safety Assessment

Non Small Cell Lung Cancer | Malignant Pleural Mesothelioma
Lone Baandrup
Glostrup University Hospital, Copenhagen; Copenhagen Trial Unit, Center for...

Completed

Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia (SMART)

Schizophrenia | Schizoaffective Disorder | Bipolar Affective Disorder

Denmark
Allergan

Terminated

Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Spasmodic Torticollis

Argentina, India, Australia
Alkermes, Inc.

Completed

ALK21-006: Long-Term Study of Medisorb® Naltrexone (VIVITROL®)

Alcoholism
University of Parma

Terminated

Controlled-Release Oxycodone For Postoperative Analgesia After Video-Assisted Thoracic Surgery

Pain, Postoperative | Anesthesia Recovery Period

Italy
Skin Laser & Surgery Specialists
Galderma R&D

Terminated

Mirvaso® Gel and Dysport® for Erythema and Flushing of Rosacea

Erythema and Flushing Associated With Rosacea
Birmingham Women's NHS Foundation Trust
Smith & Nephew, Inc.

Completed

A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps (MERT)

Endometrial Polyps

United Kingdom
Universidade Federal de Pernambuco

Completed

Acapella With Nebulization in Normal Subjects

Healthy
Luye Pharma Group Ltd.

Completed

Efficacy and Safety of LY01005 in Patients With Breast Cancer Compared to ZOLADEX®

Breast Cancer

China
Washington University School of Medicine
St. Louis University

Terminated

Treatment Utility of Postpartum Antibiotics in Chorioamnionitis (TUPAC)

The Primary Outcome of This Study Will be the Rate of Endometritis

United States
Bernhard Nocht Institute for Tropical Medicine
German Federal Ministry of Education and Research

Terminated

Probiotic Saccharomyces Boulardii for the Prevention of Antibiotic-associated Diarrhoea (SacBo)

Diarrhea | Antibiotic-associated Diarrhea | Clostridium Difficile

Germany
Oklahoma State University

Recruiting

Gut Permeability-related Inflammation and Cardiovascular Disease Risk in Normal-weight and Metabolically Healthy Obesity

Obesity

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

Influenza

United States
Organon and Co

Completed

Efficacy and Safety Study of Ezetimibe (SCH 58235, MK-0653) in Addition to Atorvastatin in Participants With Coronary Heart Disease or Multiple Cardiovascular Risk Factors (P00693/MK-0653-030)

Hypercholesterolemia
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Serum Collection for Immunogenicity and Safety Evaluation in Healthy Children Receiving Fluzone®

Influenza | Orthomyxoviridae Infections

United States
H. Lundbeck A/S
Otsuka Pharmaceutical Co., Ltd.

Completed

Brexpiprazole in Patients With Acute Schizophrenia

Schizophrenia

United States
AboutSkin Dermatology and DermSurgery, PC
Allergan

Completed

Study of BOTOX and JUVEDERM for Treatment of Moderate to Severe Facial Wrinkles and Folds (JUVE_BTX)

Wrinkles

United States, Canada
Allergan

Completed

Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines

Glabellar Lines | Crow's Feet Lines | Facial Rhytides

Germany, Canada, United States, France
Biofrontera Bioscience GmbH

Active, not recruiting

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

Superficial Basal Cell Carcinoma

United States

3

Subscribe